The production of commercial dose non-sterile products such as tablets, capsules, ointments, creams, and powders is rising due to their growing global demand, attributed to increasing demand for anti-ageing products, hereditary factors, genetic mutations, exposure to harmful radiation, and rising geriatric population.
Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market.
Identifying the top commercial dose (non-sterile) companies in contract marketing
Pharmaceutical Technology has listed the leading commercial dose non-sterile companies in contract marketing based on its intel, insights, and decades of experience in the sector. The list includes companies that provide various products and services, including but not limited to:
- Product launch and distribution
- Technology transfer
- Product supply management
- Creating brand awareness
- Lead generation
- Management consulting
- Research and insights
- Data and analytics services
- Price optimisation and reimbursement, and
- Market penetration and expansion
The information contained within the download document is intended for pharmaceutical manufacturers, wholesalers, retailers and distributors, pharmaceutical executives, medical representatives, business development managers, retail salesmen, sales managers, pharmacy executives, and any other individual involved in pharmaceutical marketing.
The document contains detailed information on the suppliers and their products, alongside contact details to aid your purchasing or hiring decisions.
Trends and technologies influencing non-sterile commercial dose products
Newly emerging technologies have helped in improving the effectiveness and safety of non-sterile commercial dose products. Robotics, for example, has facilitated the automation of medicine preparation and distribution, controlled drug delivery systems, and machine-readable coding on medicine packages.
Some of the trends and technologies influencing the development, manufacturing and marketing of commercial dose non-sterile products include smaller footprint processes, fully automated small-scale synthetic chemistry systems, flow-based API manufacturing processes, hot-melt extrusion, extrusion-spheronisation, spray drying, and digital marketing platforms.